9 Results for "

α9α10

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "α9α10" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-12152
CAS No.: 501925-31-1
Purity:  99.49%
Synonyms: NSC 216666
Target:  

nAChR

PNU-120596 (NSC 216666) is a potent and selective α7 nAChR positive allosteric modulator (PMA) that can cross the blood-brain barrier, with an EC50 of 216 nM. PNU-120596 is inactive against α4β2, α3β4, and α9α10 nAChRs. PNU-120596 has the potential for psychiatric and neurological disorders research .
loading...
    loading...
Cat. No.: HY-P10898
CAS No.: 2900996-95-2
Research Areas:  

Neurological Disease

GeX-2 is a truncated analogue of αO-conotoxin. GeX-2 activates GABAB receptor. GeX-2 inhibits α9α10 nAChR and CaV2.2 channels. GeX-2 alleviates pain in the rat model of chronic constriction injury .
loading...
    loading...
Cat. No.: HY-138973A
CAS No.: 457068-92-7
Target:  

iGluR nAChR

Research Areas:  

Neurological Disease

Neramexane mesylate is an α9α10 cholinergic nicotinic receptors and N-methyl-D-aspartate receptors(NMDA) antagonist. Neramexane mesylate can improve moderate to severe tinnitus, and also shows neuroprotective effects .
loading...
    loading...
Cat. No.: HY-P11249
Target:  

nAChR

Research Areas:  

Neurological Disease

Mr1.1[S4Dap, C16Pen] is a highly active and selective nAChR (human α9α10 nAChR IC50 = 4.0 nM, rat α9α10 nAChR IC50 = 2.7 nM) inhibitor. Mr1.1[S4Dap, C16Pen] can significantly relieve pain and has significant stability. Mr1.1[S4Dap, C16Pen] can be used for the study of neuropathic pain .
loading...
    loading...
Cat. No.: HY-P11470
CAS No.: 3093661-13-0
Target:  

nAChR SARS-CoV

Research Areas:  

Infection

Conofurin-Delta is a potent α7 nAChR inhibitor with an IC50 of 177 nM. Conofurin-Delta also inhibits α9α10 nAChR with an IC50 of 98.1 nM. Conofurin-Delta may be used in SARS-CoV-2 infection research .
loading...
    loading...
Cat. No.: HY-N16997
CAS No.: 469-86-3
Synonyms: [5α,9α,10β,(+)]-Kaur-16-ene
(+)-Phyllocladene ([5α,9α,10β,(+)]-Kaur-16-ene) is a natural diterpene.
loading...
    loading...
Cat. No.: HY-180559
Research Areas:  

Inflammation/Immunology

nAChR antagonist 2 is a selective nAChR antagonist. nAChR antagonist 2 inhibits nAChR subtype including hα9α10, hα9, and hα7 with IC50 values of 16.0 nM, 26.2 nM, and 336.3 nM, respectively, in Xenopus oocytes. nAChR antagonist 2 suppresses ATP-induced IL-1β release at nanomolar concentrations. nAChR antagonist 2 can be used for nonopioid analgesics and immunomodulators research .
loading...
    loading...
Cat. No.: HY-P11860
Target:  

nAChR

Research Areas:  

Neurological Disease

WrFr-OCH3 is a competitive nAChR inhibitor, with IC50 values of 291.9 nM, 25.3 nM, 477.5 nM and 36.5 nM against hα1β1εδ nAChR, hα9α10 nAChR, hα7 nAChR and hα9 nAChR, respectively. WrFr-OCH3 exhibits analgesic and muscle relaxant effects, reduces forelimb grip strength in rats, and alleviates Oxaliplatin (HY-17371)-induced cold allodynia in rats. WrFr-OCH3 can be used in studies related to cold allodynia .
loading...
    loading...
Cat. No.: HY-180400
CAS No.: 1426293-61-9
Target:  

nAChR Calcium Channel

Research Areas:  

Neurological Disease

PAM-2 is a potent, orally active, CNS-penetrant selective α7 nAChR positive allosteric modulator (human α7 nAChR EC50: 39 μM, rat α7 nAChR EC50: 12 μM) with anti-nociceptive and anti-inflammatory activity. PAM-2 exhibits selectivity over α9α10 nAChR (IC50 = 174 μM) and CaV2.2 channel (IC50 = 89 μM). PAM-2 decreases Streptozotocin (STZ) (HY-13753)- and Oxaliplatin (HY-17371)-inducned nuroparhic pain in mice by α7 nAChR potentiation. PAM-2 can be used for the research of neuropathic pain .
loading...
    loading...